250 related articles for article (PubMed ID: 8770930)
1. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat.
Iwasaki H; Hirata Y; Iwashina M; Sato K; Marumo F
Endocrinology; 1996 Jul; 137(7):3045-50. PubMed ID: 8770930
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells.
Eguchi S; Hirata Y; Iwasaki H; Sato K; Watanabe TX; Inui T; Nakajima K; Sakakibara S; Marumo F
Endocrinology; 1994 Dec; 135(6):2454-8. PubMed ID: 7988431
[TBL] [Abstract][Full Text] [Related]
3. Proadrenomedullin N-terminal 20 peptide inhibits aldosterone secretion of human adrenocortical and Conn's adenoma cells: comparison with adrenomedullin effect.
Andreis PG; Tortorella C; Mazzocchi G; Nussdorfer GG
J Clin Endocrinol Metab; 1998 Jan; 83(1):253-7. PubMed ID: 9435451
[TBL] [Abstract][Full Text] [Related]
4. Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides.
Kamohara M; Matsuo A; Takasaki J; Kohda M; Matsumoto M; Matsumoto S; Soga T; Hiyama H; Kobori M; Katou M
Biochem Biophys Res Commun; 2005 May; 330(4):1146-52. PubMed ID: 15823563
[TBL] [Abstract][Full Text] [Related]
5. Investigation and characterization of binding sites for islet amyloid polypeptide in rat membranes.
Bhogal R; Smith DM; Bloom SR
Endocrinology; 1992 Feb; 130(2):906-13. PubMed ID: 1310282
[TBL] [Abstract][Full Text] [Related]
6. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla.
Kuwasako K; Kitamura K; Ichiki Y; Kato J; Kangawa K; Matsuo H; Eto T
Biochem Biophys Res Commun; 1995 Jun; 211(2):694-9. PubMed ID: 7794284
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone augments adrenomedullin production without stimulating pro-adrenomedullin N-terminal 20 peptide secretion in vascular smooth muscle cells.
Uemura T; Kato J; Kuwasako K; Kitamura K; Kangawa K; Eto T
J Hypertens; 2002 Jun; 20(6):1209-14. PubMed ID: 12023693
[TBL] [Abstract][Full Text] [Related]
8. Decrease of TSH levels and epithelium/colloid ratio in rat thyroid glands following administration of proadrenomedullin N-terminal peptide (12-20).
Ginda WJ; Nowak KW; Malendowicz LK
Horm Metab Res; 2000 Jan; 32(1):10-4. PubMed ID: 10727007
[TBL] [Abstract][Full Text] [Related]
9. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells.
Eguchi S; Hirata Y; Kano H; Sato K; Watanabe Y; Watanabe TX; Nakajima K; Sakakibara S; Marumo F
FEBS Lett; 1994 Mar; 340(3):226-30. PubMed ID: 8131850
[TBL] [Abstract][Full Text] [Related]
10. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat.
Owji AA; Smith DM; Coppock HA; Morgan DG; Bhogal R; Ghatei MA; Bloom SR
Endocrinology; 1995 May; 136(5):2127-34. PubMed ID: 7720662
[TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells.
Ishizaka Y; Ishizaka Y; Tanaka M; Kitamura K; Kangawa K; Minamino N; Matsuo H; Eto T
Biochem Biophys Res Commun; 1994 Apr; 200(1):642-6. PubMed ID: 8166740
[TBL] [Abstract][Full Text] [Related]
12. Effects of N-terminal, midregion, and C-terminal parathyroid hormone-related peptides on adenosine 3',5'-monophosphate and cytoplasmic free calcium in rat aortic smooth muscle cells and UMR-106 osteoblast-like cells.
Wu S; Pirola CJ; Green J; Yamaguchi DT; Okano K; Jueppner H; Forrester JS; Fagin JA; Clemens TL
Endocrinology; 1993 Dec; 133(6):2437-44. PubMed ID: 8243262
[TBL] [Abstract][Full Text] [Related]
13. Effects of different peptide fragments derived from proadrenomedullin on gene expression of adrenomedullin gene.
Qi YF; Bu DF; Niu DD; Shi YR; Wang SH; Pang YZ; Tang CS; Du JB
Peptides; 2002 Jun; 23(6):1141-7. PubMed ID: 12126743
[TBL] [Abstract][Full Text] [Related]
14. Proadrenomedullin N-terminal 20-peptide (PAMP) receptors and signal transduction in the rat adrenal gland.
Hinson JP; Hagi-Pavli E; Thomson LM; Kapas S
Life Sci; 1998; 62(5):439-43. PubMed ID: 9449234
[TBL] [Abstract][Full Text] [Related]
15. Comparative affinities of adrenomedullin (AM) and calcitonin gene-related peptide (CGRP) for [125I] AM and [125I] CGRP specific binding sites in porcine tissues.
Dang K; Disa J; Gout B; Aiyar N
J Recept Signal Transduct Res; 1999 Sep; 19(5):803-17. PubMed ID: 10349595
[TBL] [Abstract][Full Text] [Related]
16. Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat.
Inatsu H; Sakata J; Shimokubo T; Kitani M; Nishizono M; Washimine H; Kitamura K; Kangawa K; Matsuo H; Eto T
Biochem Mol Biol Int; 1996 Feb; 38(2):365-72. PubMed ID: 8850532
[TBL] [Abstract][Full Text] [Related]
17. Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line.
Perry KJ; Quiza M; Myers DE; Morfis M; Christopoulos G; Sexton PM
Endocrinology; 1997 Aug; 138(8):3486-96. PubMed ID: 9231803
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a biotinylated somatostatin analog as a receptor probe.
Schonbrunn A; Lee AB; Brown PJ
Endocrinology; 1993 Jan; 132(1):146-54. PubMed ID: 8093437
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine.
Washimine H; Kitamura K; Ichiki Y; Yamamoto Y; Kangawa K; Matsuo H; Eto T
Biochem Biophys Res Commun; 1994 Jul; 202(2):1081-7. PubMed ID: 8048921
[TBL] [Abstract][Full Text] [Related]
20. [Adrenomedullin and PAMP].
Kitamura K; Eto T
Nihon Rinsho; 1997 Aug; 55(8):1963-70. PubMed ID: 9284408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
